현대 정신의학은 어떻게 우울증을 이해하고 있나? = What is Depression? From the Viewpoint of Modern Psychiatry

다국어 초록 (Multilingual Abstract)

Depression is heterogeneous in terms of its clinical aspect, diagnosis, cause, neurobiology, drug response and course. Because of the heterogeneity of major depressive disorder (MDD), DSM-IV classified MDD into various subtypes, such as melancholic, atypical, severe with psychotic feature, severe without psychotic feature, with postpartum onset, with catatonic feature, early-onset, late-onset, chronic, single or recurrent. In spite of the efforts of many clinicians trying to classify and explain the nature of MDD, depression is still qualified as a syndrome rather than a disease. When we see patients with MDD in clinical setting, we still use several subtypes of classical classification in order to comprehend the patient better. Psychiatrist should treat the patients with MDD according to their specific features and integrate the various information from them. For these reasons, depression is regarded as a complicated disease to identify and treat. Therefore, mental health professionals, especially psychiatrists should bu trained on these diverse characteristics of MDD and it is rccommended that the treatment of depression should be referred to a psychiatrist.

참고문헌 (Reference)

1 이상혁, "노년기 우울증과 스트레스" 대한스트레스학회 15 (15): 295-301, 2007

2 Rush AJ, "xDexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression" 41 : 915-928, 1997

3 Chaudron LH, "relationship between postpartum psychosis and bipolar disorder: a review" 64 : 1284-1292, 2003

4 Weissman MM, "Wickramaratne P, Prusoff BA. Early-onset major depression in patients and their children" 15 : 269-277, 1988

5 Sohn CH, "Update on the biology of seasonal affective disorder" 10 : 635-646, 2005

6 Rush AJ, "The varied clinical presentations of major depressive disorder" 8 : 4-10, 2007

7 Thase ME, "The role of Axis II comorbidity in the management of patients with treatment-resistant depression" 19 : 287-309, 1996

8 Lee SH, "The relationship between treatment response with clinical variables in major depressive disorder" 199-, 2006

9 Wilhelm K, "The relationship between interpersonal sensitivity, anxiety disorders and major depression" 79 : 33-41, 2004

10 Gomez RG, "The neuropsychological profile of psychotic major depression and its relation to cortisol" 60 : 472-478, 2006

11 Demyttenaere K, "The many faces of fatigue in major depressive disorder" 8 : 93-105, 2005

12 Leventhal AM, "The empirical status of melancholia: implications for psychology" 25-44, 2005

13 Golden RN, "The efficacy of light therapy in the treatment of mood disorder: a review and meta-analysis of the evidence" 162 : 656-662, 2005

14 Seok JH, "The conditional and characteristic factors of patients with major depressive disorder examined with clinical scales" 198-, 2006

15 Austin MP, "Targeted group antenatal prevention of postnatal depression: a review" 107 : 244-250, 2003

16 Kovacs M, "Suicidal behaviors and childhoodonset depressive disorders: a longitudinal investigation" 32 : 8-20, 1993

17 Kennedy SH, "Sexual dysfunction before antidepressant therapy in major depression" 56 : 201-208, 1999

18 Khan A, "Severity of depression and response to antidepressant and placebo: an analysis of the Food and Drug Administration database" 22 : 40-45, 2002

19 Bloch M, "Risk factors associated with the development of postpartum mood disorders" 88 : 9-18, 2005

20 Ramana R, "Remission and relapse in major depression: a two-year prospective follow-up study" 25 : 1161-1170, 1995

21 Thase ME, "Recognition and diagnosis of atypical depression" 68 (68): 11-16, 2007

22 Coryell W, "Psychotic depression" 57 (57): 27-31, 1996

23 Park SS, "Psychosocial risk factors of postpartum depression" 7 : 124-133, 1999

24 Ohayon MM, "Prevalence of depressive episodes with psychotic features in the general population" 159 : 1855-1861, 2002

25 Wijkstra J, "Pharmacological treatment for psychotic depression" 2005

26 Terman M, "On the question of mechanism in phototherapy for seasonal affective disorder: considerations of clinical efficacy and epidemiology" 3 : 155-172, 1988

27 Fleming SK, "Neuropsychological correlates of psychotic features in major depressive disorder: a review and meta-analysis" 38 : 27-35, 2004

28 Raison CL, "Neuropsychiatric adverse effects of interferon-alpha: recognition and management" 19 : 105-123, 2005

29 Porter RJ, "Neurocognitive impairment in drug-free patients with major depressive disorder" 182 : 214-220, 2003

30 Bartolini M, "Motivational symptoms of depression mask preclinical Alzheimer’s disease in elderly subjects" 19 : 31-36, 2005

31 Kessler RC, "Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication" 62 : 593-602, 2005

32 Breslau N, "Major depression and stages of smoking. A longitudinal investigation" 55 : 161-166, 1998

33 Boivin DB, "Influence of sleep-wake and circadian rhythm disturbances in psychiatric disorders" 25 : 446-458, 2000

34 Keller MB, "Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression" 44 : 348-360, 1998

35 Breslau N, "Headache and major depression: is the association specific to migraine?" 54 : 308-313, 2000

36 Drevets WC, "Functional anatomical abnormalities in limbic and prefrontal cortical structures in major depression" 126 : 413-431, 2000

37 Gilmer WS, "Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project" 112 : 425-433, 2005

38 Alexopoulos GS, "Executive dysfunction, heart disease burden, and remission of geriatric depression" 29 : 2278-2284, 2004

39 Kasper S, "Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland" 46 : 823-833, 1989

40 Rosenthal NE, "Effects of light treatment on core body temperature in seasonal affective disorder" 27 : 39-50, 1990

41 Russell JM, "Effect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression" 13 : 18-27, 2001

42 Björntorp P, "Do stress reactions cause abdominal obesity and comorbidities?" 2 : 73-86, 2001

43 Lyketsos CG, "Diagnosis and treatment of depression in Alzheimer’s disease. A practical update for the clinician" 17 : 55-64, 2004

44 Miller GE, "Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease" 59 : 231-236, 2005

45 Siris SG, "Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents" 157 : 1379-1389, 2000

46 McWilliams LA, "Depression and anxiety associated with three pain conditions: results from a nationally representative sample" 111 : 77-83, 2004

47 Otte C, "Depression and 24-hour urinary cortisol in medical outpatients with coronary heart disease: The Heart and Soul Study" 56 : 241-247, 2004

48 American Psychiatric Association, "DSM-IV-TR Text Revision: Diagnostic and Statistical Manual for Mental Disorders, 4th ed" American Psychiatric Press 2000

49 Rush AJ, "DSM-IV mood disorders: final overview ; DSM-IV Sourcebook, vol 4" American Psychiatric Press 1019-1033, 1998

50 Dannon PN, "Current and emerging somatic treatment strategies in psychotic major depression" 6 : 73-80, 2006

51 Overbeek T, "Comorbidity of obsessive- compulsive disorder and depression: prevalence, symptom severity, and treatment effect" 63 : 1106-1112, 2002

52 Kessler RC, "Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey" 30 : 17-30, 1996

53 Fineberg NA, "Comorbid depression in obsessive compulsive disorder (OCD): symptomatic differences to major depressive disorder" 87 : 327-330, 2005

54 Bosboom JL, "Cognitive dysfunction and dementia in Parkinson's disease" 111 : 1303-1315, 2004

55 Brady KT, "Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress" 162 : 1483-1493, 2005

56 Fava M, "Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder" 34 : 1299-1308, 2004

57 Sarter M, "Choline transporters, cholinergic transmission and cognition" 6 : 48-56, 2005

58 Mayeux R, "Behavioral manifestations of movement disorders. Parkinson’s and Huntington’s disease" 2 : 527-540, 1984

59 Capuron L, "Baseline mood and psychosocial characteristics of patients developing depressive symptoms during interleukin-2 and/or interferon-alpha cancer therapy" 18 : 205-213, 2004

60 Onder G, "Association between pain and depression among older adults in Europe: results from the Aged in Home Care (AdHOC) project: a cross-sectional study" 66 : 982-988, 2005

61 Egeland J, "Asbjornsen A, Lund A, et al. Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance" 108 : 275-284, 2003

62 Whitehead C, "Antidepressants for the treatment of depression in people with schizophrenia: a systematic review" 33 : 589-599, 2003

63 Montgomery SA, "Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction" 69 : 119-140, 2002

64 Klein DN, "A family study of major depressive disorder in a community sample of adolescents" 58 : 13-20, 2001